InvestorsHub Logo

frrol

03/03/15 4:47 PM

#93381 RE: JTORENCE #93377

JT: Brilacidin's trial for ABSSSI has finished Phase 2; the Phase 2 trial for Oral Mucositis (OM) hasn't started yet. They are two very different indications, and thus two different trials.